Morgan Stanley Alx Oncology Holdings Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Morgan Stanley holds 320,772 shares of ALXO stock, worth $542,104. This represents 0.0% of its overall portfolio holdings.

Number of Shares

320,772

Previous 673,358 52.36%

Holding current value

$542,104

Previous $4.06 Million 85.64%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.81 - $8.13 $638,180 - $2.87 Million	-352,586 Reduced 52.36%	320,772 $583,000
Q2 2024 Oct 17, 2024	BUY	$5.84 - $17.56 $1.93 Million - $5.8 Million	330,221 Added 96.24%	673,358 $4.06 Million
Q2 2024 Aug 14, 2024	BUY	$5.84 - $17.56 $1.93 Million - $5.8 Million	330,221 Added 96.24%	673,358 $4.06 Million
Q1 2024 Oct 17, 2024	SELL	$10.95 - $16.79 $3.62 Million - $5.54 Million	-330,221 Reduced 49.04%	343,137 $3.83 Million
Q1 2024 Aug 16, 2024	SELL	$10.95 - $16.79 $773,683 - $1.19 Million	-70,656 Reduced 17.08%	343,137 $3.83 Million
Q1 2024 May 15, 2024	SELL	$10.95 - $16.79 $773,683 - $1.19 Million	-70,656 Reduced 17.08%	343,137 $3.83 Million
Q4 2023 Aug 16, 2024	SELL	$4.81 - $15.38 $1.25 Million - $3.99 Million	-259,565 Reduced 38.55%	413,793 $6.16 Million
Q4 2023 Feb 13, 2024	BUY	$4.81 - $15.38 $386,291 - $1.24 Million	80,310 Added 24.08%	413,793 $6.16 Million
Q3 2023 Nov 15, 2023	BUY	$4.19 - $7.35 $379,769 - $666,181	90,637 Added 37.32%	333,483 $1.6 Million
Q2 2023 Aug 14, 2023	SELL	$4.37 - $9.56 $311,755 - $682,010	-71,340 Reduced 22.71%	242,846 $1.82 Million
Q1 2023 May 15, 2023	SELL	$4.52 - $11.71 $778,036 - $2.02 Million	-172,132 Reduced 35.39%	314,186 $1.42 Million
Q4 2022 Feb 14, 2023	BUY	$9.51 - $12.95 $852,866 - $1.16 Million	89,681 Added 22.61%	486,318 $5.48 Million
Q3 2022 Nov 14, 2022	SELL	$8.23 - $15.14 $389,262 - $716,091	-47,298 Reduced 10.65%	396,637 $3.8 Million
Q2 2022 Oct 27, 2022	BUY	$5.89 - $19.46 $349,966 - $1.16 Million	59,417 Added 15.45%	443,935 $3.59 Million
Q2 2022 Aug 15, 2022	BUY	$5.89 - $19.46 $349,966 - $1.16 Million	59,417 Added 15.45%	443,935 $3.59 Million
Q1 2022 Oct 27, 2022	SELL	$13.65 - $22.06 $811,042 - $1.31 Million	-59,417 Reduced 13.38%	384,518 $6.5 Million
Q1 2022 May 13, 2022	BUY	$13.65 - $22.06 $1.77 Million - $2.86 Million	129,818 Added 50.97%	384,518 $6.5 Million
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $3.72 Million - $12.9 Million	173,280 Added 212.82%	254,700 $5.47 Million
Q3 2021 Nov 15, 2021	BUY	$52.51 - $80.91 $4.28 Million - $6.59 Million	81,420 New	81,420 $6.01 Million

Others Institutions Holding ALXO

# of Institutions

101

Shares Held

39.7M

Call Options Held

134K

Put Options Held

17.4K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $68.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account